Prolonged interleukin-2 (IL-2) treatment can augment immune activation without enhancing antitumor activity in renal cell carcinoma.

about

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.Cytokines as clinical adjuvants: how far are we?Natural killer cells: role in local tumor growth and metastasis

P2860

Q35062106-22CC208F-AA3C-4416-8792-A6DF1D62D1D1 Q35192213-4FC4E4C3-A1B1-4516-A9A2-47C9F09FF34D Q35905953-18B03220-5204-4025-8B7F-EB15C95909DE

P2860

Prolonged interleukin-2 (IL-2) treatment can augment immune activation without enhancing antitumor activity in renal cell carcinoma.

Item

http://www.wikidata.org/entity/Q37686896

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 1991

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prolonged interleukin-2 (IL-2) ...... ivity in renal cell carcinoma.

@en

Prolonged interleukin-2

@nl

type

Item

label

Prolonged interleukin-2 (IL-2) ...... ivity in renal cell carcinoma.

@en

Prolonged interleukin-2

@nl

prefLabel

Prolonged interleukin-2 (IL-2) ...... ivity in renal cell carcinoma.

@en

Prolonged interleukin-2

@nl

P1476

Prolonged interleukin-2 (IL-2) ...... ivity in renal cell carcinoma.

@en

P2093

Albertini MR

http://www.w3.org/2001/XMLSchema#string

Bechhofer R

http://www.w3.org/2001/XMLSchema#string

Borchert A

http://www.w3.org/2001/XMLSchema#string

Goldstein D

http://www.w3.org/2001/XMLSchema#string

Hank JA

http://www.w3.org/2001/XMLSchema#string

Kohler PC

http://www.w3.org/2001/XMLSchema#string

Moore KH

http://www.w3.org/2001/XMLSchema#string

Schell K

http://www.w3.org/2001/XMLSchema#string

Sosman JA

http://www.w3.org/2001/XMLSchema#string

Storer B

http://www.w3.org/2001/XMLSchema#string

P2860

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Phase II trial of outpatient interleukin-2 in malignant lymphoma, chronic lymphocytic leukemia, and selected solid tumors.

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.

Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.

Selective in vitro growth of T lymphocytes from normal human bone marrows.

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

Immunotherapy of a murine tumor with interleukin 2. Increased sensitivity after MHC class I gene transfection

Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia

P304

35-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/07357909109032798

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1991-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2012995

http://www.w3.org/2001/XMLSchema#string

P921

interleukin

Prolonged interleukin-2 (IL-2) treatment can augment immune activation without enhancing antitumor activity in renal cell carcinoma.

about

P2860

P2860

Prolonged interleukin-2 (IL-2) treatment can augment immune activation without enhancing antitumor activity in renal cell carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921